InvestorsHub Logo
Followers 230
Posts 14783
Boards Moderated 1
Alias Born 03/29/2014

Re: MI Dendream post# 439611

Saturday, 01/29/2022 3:09:33 PM

Saturday, January 29, 2022 3:09:33 PM

Post# of 708800

Senti, Did that shareholder meeting preceed about March of 2015 or a little bit later or was it after the fact?



I went back and looked when Les spoke with Ike regarding the additional 31 patients... the question was asked and answered prior to the 2019 ASM on January 31, 2019. A bunch of us on this board listed and voted for the questions we wanted asked of management at the ASM. Ike took the list of questions and submitted them to Les AND Linda via email.

Les called Ike back and gave him the answers. Regarding the 31 patients who were enrolled in the trial AFTER the screening halt, this is what Les told Ike (remember, LP was also sent the list of questions). FYI: the number 18 in the quote below simply means that was the number of the question from the list we'd all voted on.

4. (18 Distribution of final 31 patients): ALL PATIENTS WERE RANDOMIZED You can't just put a group in one arm or the other. NWBO had nothing to do with which patients ended up in which arm. Because of the large number of sites, the final randomization may not have been exactly 2:1 but may have been off by a few people one way or the other.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=146490681



The bold, red, cap emphasis is mine.

And here is the response to a question regarding the hold:

3. (01 Hold): The FDA was involved with the hold and discussing it right before applying for approval does not seem like a wise thing to do.



So there you have it folks. Feel free to keep thinking the randomization was otherwise, but this is what the company has said, many times, trust me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News